Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines (original) (raw)

References

  1. Olovnikov, A.M. Principle of marginotomy in template synthesis of polynucleotides. Doklady Biochem. 201, 394–397 (1971).
    Google Scholar
  2. Harley, C.B., Futcher, A.B. & Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990).
    Article CAS PubMed Google Scholar
  3. Hastie, N.D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990).
    Article CAS PubMed Google Scholar
  4. Greider, C.W. & Blackburn, E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405–413 (1985).
    Article CAS PubMed Google Scholar
  5. Harley, C.B. Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res. 256, 271–282 (1991).
    Article CAS PubMed Google Scholar
  6. Kim, N.W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
    Article CAS PubMed Google Scholar
  7. Bacchetti, S. & Counter, C.M. Telomeres and telomerase in human cancer. Int. J. Oncology 7, 423–432 (1995).
    CAS Google Scholar
  8. Murnane, J.P., Sabatier, L., Marder, B.A. & Morgan, W.F. Telomere dynamics in an immortal human cell line. EMBO J. 13, 4953–4962 (1994).
    Article CAS PubMed PubMed Central Google Scholar
  9. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240–4248 (1995).
    Article CAS PubMed PubMed Central Google Scholar
  10. Rogan, E.M. et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalisation of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15, 4745–4753 (1995).
    Article CAS PubMed PubMed Central Google Scholar
  11. Bryan, T.M. & Reddel, R.R. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer, 33, 767–773 (1997).
    Article CAS PubMed Google Scholar
  12. Whitaker, N.J. et al. Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells. Oncogene 11, 971–976 (1995).
    CAS PubMed Google Scholar
  13. Piatyszek, M.A. et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci. 17, 1–15 (1995).
    Article Google Scholar
  14. Wright, W.E., Shay, J.W. & Piatyszek, M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23, 3794–3795 (1995).
    Article CAS PubMed PubMed Central Google Scholar
  15. Counter, C.M., Hirte, H.W., Bacchetti, S. & Harley, C.B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA 91, 2900–2904 (1994).
    Article CAS PubMed PubMed Central Google Scholar
  16. Hiyama, K. et al. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87, 895–902 (1995).
    Article CAS PubMed Google Scholar
  17. Hiyama, E. et al. Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88, 116–122 (1996).
    Article CAS PubMed Google Scholar
  18. Sugino, T. et al. Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates. Int. J. Cancer 69, 301–306 (1996).
    Article CAS PubMed Google Scholar
  19. Taylor, R.S. et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106, 759–765 (1996).
    Article CAS PubMed Google Scholar
  20. Mehle, C., Piatyszek, M.A., Ljungberg, B., Shay, J.W. & Roos, G. Telomerase activity in human renal Cell carcinoma. Oncogene 13, 161–166 (1996).
    CAS PubMed Google Scholar
  21. Hiyama, E., Hiyama, K., Yokoyama, T., Ichikawa, T. & Matsuura, Y. Length of telomeric repeats in neuroblastorna: Correlation with prognosis and other biological characteristics. Jpn. J. Cancer Res. 83, 159–164 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  22. Nürnberg, P., Thiel, G., Weber, F. & Epplen, J.T. Changes of telomere lengths in human intracranial tumours. Hum. Genet. 91, 190–192 (1993).
    Article PubMed Google Scholar
  23. Klingelhutz, A.J., Foster, S.A. & McDougall, J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79–82 (1996).
    Article CAS PubMed Google Scholar
  24. Hiyama, E. et al. Telomerase activity in human intestine. Int. J. Oncology 9, 453–458 (1996).
    CAS Google Scholar
  25. Härle-Bachor, C. & Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93, 6476–6481 (1996).
    Article PubMed PubMed Central Google Scholar
  26. Yasumoto, S. et al. Telomerase activity in normal human epithelial cells. Oncogene 13, 433–439 (1996).
    CAS PubMed Google Scholar
  27. Hsiao, R., Sharma, H.W., Ramakrishnan, S., Keith, E. & Narayanan, R. Telomerase activity in normal human endothelial cells. Anticancer Res. 17, 827–832 (1997).
    CAS PubMed Google Scholar
  28. Warneford, S.G. et al. Germ-line splicing mutation of the p53 gene in a cancer-prone family. Cell Growth Differ. 3, 839–846 (1992).
    CAS PubMed Google Scholar
  29. Noble, J.R. et al. Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene 13, 1259–1268 (1996).
    CAS PubMed Google Scholar
  30. Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene. Nature 351, 453–456 (1991).
    Article CAS PubMed Google Scholar
  31. Duncan, E.L., Whitaker, N.J., Moy, E.L. & Reddel, R.R. Assignment of SV40-immortalized cells to more than one complementation group for immortalization. Exp. Cell Res. 205, 337–344 (1993).
    Article CAS PubMed Google Scholar
  32. Gupta, J., Han, L.-P., Wang, P., Gallie, B.L. & Bacchetti, S. Development of retinoblastoma in the absence of telomerase activity. J. Natl. Cancer Inst. 88, 1152–1157 (1996).
    Article CAS PubMed Google Scholar
  33. Kyrion, G., Boakye, K.A. & Lustig, A.J. C-terminal truncation of RAP1 results in the deregulation of telomere size, stability and function in Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 5159–5173 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  34. Krauskopf, A. & Blackburn, E.H. Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats. Nature 383, 354–357 (1996).
    Article CAS PubMed Google Scholar
  35. Lundblad, V. & Blackburn, E.H. An alternative pathway for yeast telomere maintenance rescues _est1_− senescence. Cell 73, 347–360 (1993).
    Article CAS PubMed Google Scholar
  36. McEachern, M.J. & Blackburn, E.H. Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev. 10, 1822–1834 (1996).
    Article CAS PubMed Google Scholar
  37. Chadeneau, C., Hay, K., Hirte, H.W., Gallinger, S. & Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533–2536 (1995).
    CAS PubMed Google Scholar
  38. Counter, C.M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921–1929 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  39. Sprung, C.N., Bryan, T.M., Reddel, R.R. & Murnane, J.P. Normal telomere maintenance in immortal ataxia telangiectasia cell lines. Mutat. Res. (in the press).

Download references